 |
Weight and HealthcareExamining weight science, weight stigma, and what evidence, ethics, and lived experience teach us about best healthcare practices and public health for higher weight people. Author: with Ragen Chastain
Examining the intersections of weight science, weight stigma, and healthcare and what evidence, ethics, and lived experience teach us about healthcare and public health best practices for higher-weight people. weightandhealthcare.substack.com Language: en Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Four-Year Outcomes of Wegovy (Semaglutide 2.4mg) Cardiovascular Study - Part 1
Saturday, 18 May, 2024
As you might imagine, I subscribe to a large number of medical publications and in the last couple of days I’ve been receiving updates from them falling all over themselves to breathlessly claim that weight loss was maintained for 4 years on Semaglutide 2.4mg (aka Wegovy) in the SELECT trial.The ways in which these claims are misleading are egregious and anti-science. In part 1 I’ll look at the initial claims and the people making them, in part 2 I’ll do a deeper analysis of the study. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe
.jpg)
